Skip to main content
Equibles

MORGAN STANLEY

Position in ZLAB — Zai Lab Ltd

CIK 895421 NEW YORK, NY
Back to ZLAB Full portfolio

Position in ZLAB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,242,619
-$532,985 QoQ
Shares Held
65,401
-30.7% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 92 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 78% Shared 0% None 22%

Common Shares in ZLAB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. ZLAB ranks #241 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in ZLAB

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,242,619 65,401
2026-03-31 $1,775,604 94,397
2025-12-31 $5,110,393 289,705
2025-09-30 $4,062,730 119,880
2025-06-30 $10,109,857 289,101
2025-03-31 $95,212,960 2,634,559
2024-12-31 $82,942,313 3,166,946
2024-09-30 $41,384,576 1,714,357
2024-06-30 $9,424,294 543,814
2024-03-31 $4,240,635 264,709
2023-12-31 $7,951,278 290,936
2023-09-30 $6,012,856 247,341
2023-06-30 $6,694,600 241,421
2023-03-31 $11,149,114 335,211
2022-12-31 $7,830,369 255,061
2022-09-30 $6,449,158 188,572
2022-06-30 $8,545,703 246,416
2022-03-31 $6,422,439 146,031
2021-12-31 $14,333,379 228,057
2021-09-30 $16,791,574 159,328
2021-06-30 $20,274,024 114,549
2021-03-31 $15,562,873 116,637
2020-12-31 $10,675,888 78,882
2020-09-30 $10,416,625 125,245
2020-06-30 $9,882,044 120,322
2020-03-31 $1,233,511 23,961